TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.
Open | $0.29 |
Close | - |
Volume / Avg. | 663.50K / 1.75M |
Day Range | 0.27 - 0.29 |
52 Wk Range | 0.26 - 128.00 |
Market Cap | $4.84M |
P/E Ratio | 0.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 0.14% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Other companies in TransCode Therapeutics’s space includes: Tharimmune (NASDAQ:THAR), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), Genprex (NASDAQ:GNPX) and Portage Biotech (NASDAQ:PRTG).
There is no analysis for TransCode Therapeutics.
TransCode Therapeutics has a consensus price target of $3.00.
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.2722 last updated Today at August 1, 2024 at 3:46 PM EDT.
There are no upcoming dividends for TransCode Therapeutics.
TransCode Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for TransCode Therapeutics.
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.